Valion Bio, Inc. (VBIO) News
Track canonical SquawkNews coverage tagged to VBIO, Valion Bio, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Valion Bio Announces US Govt Studies
Valion Bio announces US government-funded Entolimod studies
EQUITY | Aug 12, 2026, 01:31 PM UTC
H
VBIO: Pentagon Completes Protocol
Valion Bio announces the Pentagon's Armed Forces Radiobiology Research Institute and National Institute of Allergy and Infectious Diseases completed the design of a survival efficacy protocol to evaluate Entolimod for tr
EQUITY | Jun 25, 2026, 11:48 AM UTC
H
VBIO: AFRRI/NIAID Tests Entolimod
AFRRI/NIAID designs protocol to evaluate Valion Bio's Entolimod as treatment for GI-ARS
EQUITY | Jun 25, 2026, 11:47 AM UTC